JP2022532812A5 - - Google Patents
Info
- Publication number
- JP2022532812A5 JP2022532812A5 JP2021507831A JP2021507831A JP2022532812A5 JP 2022532812 A5 JP2022532812 A5 JP 2022532812A5 JP 2021507831 A JP2021507831 A JP 2021507831A JP 2021507831 A JP2021507831 A JP 2021507831A JP 2022532812 A5 JP2022532812 A5 JP 2022532812A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence identity
- amino acid
- acid sequence
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1850983 | 2018-08-16 | ||
| PCT/EP2019/071974 WO2020035577A1 (en) | 2018-08-16 | 2019-08-15 | Anti-il1rap antibody compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022532812A JP2022532812A (ja) | 2022-07-20 |
| JP2022532812A5 true JP2022532812A5 (enExample) | 2022-08-12 |
Family
ID=67667857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507831A Pending JP2022532812A (ja) | 2018-08-16 | 2019-08-15 | 抗ｉｌ１ｒａｐ抗体組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12209131B2 (enExample) |
| EP (1) | EP3837283B1 (enExample) |
| JP (1) | JP2022532812A (enExample) |
| CN (1) | CN112638946A (enExample) |
| WO (1) | WO2020035577A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022532812A (ja) | 2018-08-16 | 2022-07-20 | カンタージア アクチエボラーグ | 抗ｉｌ１ｒａｐ抗体組成物 |
| PE20231575A1 (es) | 2020-09-14 | 2023-10-04 | Ichnos Sciences SA | Anticuerpos que se unen a il1rap y usos de estos |
| MX2023007611A (es) | 2020-12-23 | 2023-07-12 | Cantargia Ab | Anticuerpo anti-il1rap. |
| EP4288457A2 (en) | 2021-02-05 | 2023-12-13 | Boehringer Ingelheim International GmbH | Anti-il1rap antibodies |
| MX2023013714A (es) | 2021-05-21 | 2024-01-16 | Leo Pharma As | Anticuerpos anti-proteina accesoria del receptor de interleucina 1 (il-1). |
| CA3226673A1 (en) * | 2021-07-21 | 2023-01-21 | Stelexis Therapeutics, Llc | Il1rap antibodies and uses thereof |
| AU2023303517A1 (en) * | 2022-07-06 | 2025-01-23 | Bluefin Biomedicine, Inc. | Methods of treating disease using anti-il1rap antibodies and antibody drug conjugates |
| CN115353566B (zh) * | 2022-09-14 | 2023-05-09 | 江苏睿源生物技术有限公司 | 用于检测白细胞介素1-β的抗体组合及其应用 |
| WO2024126833A1 (en) * | 2022-12-16 | 2024-06-20 | Ichnos Sciences SA | Cd47-il1rap bispecific antibodies |
| CN116284401B (zh) * | 2023-02-20 | 2024-09-24 | 中国人民解放军军事科学院军事医学研究院 | 人源抗il-1r3抗体及其应用 |
| JP2026517839A (ja) * | 2023-05-05 | 2026-06-02 | 大塚製薬株式会社 | 抗ｉｌ１ｒａｐ抗体 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| JPH08504172A (ja) * | 1992-06-30 | 1996-05-07 | オンコロジクス，インコーポレイティド | 抗−ｅｒｂＢ−２モノクロナール抗体の組み合わせ物及び使用方法 |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US7527787B2 (en) | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
| US7534866B2 (en) | 2005-10-19 | 2009-05-19 | Ibc Pharmaceuticals, Inc. | Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| US7550143B2 (en) | 2005-04-06 | 2009-06-23 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| DE60131456T2 (de) | 2000-11-30 | 2008-07-10 | Medarex, Inc., Milpitas | Transchromosomale transgen-nagetiere zur herstellung von humanen antikörpern |
| CA2604032C (en) | 2005-04-06 | 2017-08-22 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| JP2010116338A (ja) * | 2008-11-12 | 2010-05-27 | Evec Inc | 同一抗原に特異的に結合する複数の抗体の混合物もしくは複数の抗原結合部位を有する抗体 |
| GB2472856B (en) | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
| JP5940093B2 (ja) | 2011-01-19 | 2016-06-29 | カンタージア アクチエボラーグ | 抗ｉｌ−１ｒａｐ抗体及びヒトを処置するためのそれらの使用 |
| SI2780373T1 (sl) | 2011-11-16 | 2019-12-31 | Boehringer Ingelheim International Gmbh | Protitelesa proti IL-36R |
| GB201403875D0 (en) * | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| GB201413913D0 (en) * | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
| BR112018008908A2 (pt) * | 2015-11-02 | 2018-11-27 | Janssen Pharmaceutica Nv | anticorpos anti-il1rap, moléculas de ligação ao antígeno biespecíficas que se ligam il1rap e cd3, e seus usos |
| MX2018006333A (es) | 2015-12-01 | 2018-08-01 | Genmab Bv | Anticuerpos anti-receptor de muerte 5 (dr5) y metodos de uso de los mismos. |
| CA3084459A1 (en) | 2016-10-16 | 2018-04-19 | Cellerant Therapeutics, Inc. | Anti-il1-rap antibodies |
| WO2018071910A2 (en) | 2016-10-16 | 2018-04-19 | Cellerant Therapeutics, Inc. | Anti-il1-rap antibodies |
| JP2022532812A (ja) | 2018-08-16 | 2022-07-20 | カンタージア アクチエボラーグ | 抗ｉｌ１ｒａｐ抗体組成物 |
| MX2023007611A (es) | 2020-12-23 | 2023-07-12 | Cantargia Ab | Anticuerpo anti-il1rap. |
-
2019
- 2019-08-15 JP JP2021507831A patent/JP2022532812A/ja active Pending
- 2019-08-15 EP EP19755895.0A patent/EP3837283B1/en active Active
- 2019-08-15 US US17/267,157 patent/US12209131B2/en active Active
- 2019-08-15 WO PCT/EP2019/071974 patent/WO2020035577A1/en not_active Ceased
- 2019-08-15 CN CN201980054188.9A patent/CN112638946A/zh active Pending